Loading...
Christina Lake Cannabis Corp.
CLC.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.04
CA$0.00(0.00%)
Christina Lake Cannabis Corp. (CLC.CN) Financial Performance & Income Statement Overview
Analyze Christina Lake Cannabis Corp. (CLC.CN) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Revenue Growth
15.54%
↑ 15.54%
Operating Income Growth
451.98%
↑ 451.98%
Net Income Growth
120.93%
↑ 120.93%
Operating Cash Flow Growth
-84.00%
↓ 84.002%
Operating Margin
-12.07%
↓ 12.07%
Gross Margin
34.22%
↑ 34.22%
Net Profit Margin
6.36%
↑ 6.36%
ROE
10.65%
↑ 10.65%
ROIC
-9.61%
↓ 9.61%
Christina Lake Cannabis Corp. (CLC.CN) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Christina Lake Cannabis Corp. CLC.CN financial performance.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $3.96M | $3.33M | $3.33M | $2.99M |
| Cost of Revenue | $1.56M | $1.82M | $3.05M | $2.52M |
| Gross Profit | $2.40M | $1.50M | $288542.00 | $465213.00 |
| Gross Profit Ratio | $0.61 | $0.45 | $0.09 | $0.16 |
| R&D Expenses | $0.00 | $0.00 | $790.00 | $421.00 |
| SG&A Expenses | $2.29M | $1.04M | $1.23M | $959397.00 |
| Operating Expenses | $2.45M | $1.50M | $1.28M | $1.37M |
| Total Costs & Expenses | $4.01M | $3.03M | $4.33M | $3.89M |
| Interest Income | $3041.00 | $10588.00 | $18353.00 | $13032.00 |
| Interest Expense | $569215.00 | $438668.00 | $571254.00 | $361445.00 |
| Depreciation & Amortization | $89834.00 | $123664.00 | $146989.00 | $87430.00 |
| EBITDA | $38349.00 | $4.82M | -$851924.00 | -$755362.00 |
| EBITDA Ratio | $0.010 | $1.45 | -$0.26 | -$0.25 |
| Operating Income | -$52568.00 | $301382.00 | -$991410.00 | -$900500.00 |
| Operating Income Ratio | -$0.01 | $0.09 | -$0.30 | -$0.30 |
| Other Income/Expenses (Net) | -$568132.00 | $3.96M | -$578763.00 | -$398592.00 |
| Income Before Tax | -$620700.00 | $4.26M | -$1.57M | -$1.20M |
| Income Before Tax Ratio | -$0.16 | $1.28 | -$0.47 | -$0.40 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $44154.00 |
| Net Income | -$620700.00 | $4.26M | -$1.57M | -$1.20M |
| Net Income Ratio | -$0.16 | $1.28 | -$0.47 | -$0.40 |
| EPS | -$0.005 | $0.03 | -$0.01 | -$0.009 |
| Diluted EPS | -$0.005 | $0.03 | -$0.01 | -$0.009 |
| Weighted Avg Shares Outstanding | $131.28M | $131.12M | $130.96M | $131.12M |
| Weighted Avg Shares Outstanding (Diluted) | $131.28M | $131.12M | $130.96M | $131.12M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan